Skip to content

Magna MedTech, part of Jiří Šmejc's EMMA Capital group, buys 70% of Bulgarian medical distributor RCP

1 min read

Warehouse shelves stacked with boxes of medical supplies and dressings under bright lighting Foreign Investment
Warehouse shelves stacked with boxes of medical supplies and dressings under bright lighting

The Bulgarian supplier of medical consumables and implants had consolidated revenue of nearly €63 million and net profit of €16.7 million in 2025; the deal terms were not disclosed.

Magna MedTech, a medical technology group controlled by Czech investor Jiří Šmejc's EMMA Capital, has acquired a 70% stake in RCP, a distributor of medical devices in Bulgaria, Capital reported on 27 October.

RCP is owned by Associate Professor Racho Ribarov. The company built its business on essential hospital supplies, from gauze, bandages and cotton wool to surgical sutures, dressings and implants. It has been part of Magna MedTech since late September, according to Capital. The financial terms of the deal were not disclosed.

In 2025 Ribarov's company generated consolidated revenue of nearly €63 million from its Bulgarian and Balkan operations and a net profit of €16.7 million, Capital said.

EMMA Capital holds 65% of Magna MedTech. The remaining stake belongs to Jasna Stanivuk, owner of the Serbian medical technology company Magna Pharmacia, in which EMMA bought a 65% stake in 2024. Alongside the Bulgarian acquisition, Magna MedTech secured €155 million of financing, Capital wrote, citing international media.

The deal brings a Bulgarian medical supplies business into a regional group built from Serbia, and shows continued interest from Central European investors in healthcare distribution in South-East Europe. For Bulgarian hospitals, which buy many of these products through public tenders, the change of ownership is unlikely to change existing contracts in the short term, but it may give RCP access to more capital and a wider product range.

With a net margin of more than 25% on the reported 2025 figures, RCP is a profitable business, which helps to explain why the buyers chose a majority stake while the founder keeps a share.

Sources